about
Gemcitabine, cisplatin and vinorelbine as induction chemotherapy followed by radical therapy in stage III non-small-cell lung cancer: a multicentre study of galician-lung-cancer-group.First-line bevacizumab, cisplatin and vinorelbine plus maintenance bevacizumab in advanced non-squamous non-small cell lung cancer chemo-naïve patients.Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer. The protect-2 study.Quality of life and supportive care for patients with metastatic renal cell carcinoma.CT perfusion in oncologic imaging: a useful tool?Metastatic castration-resistant prostate cancer: changing landscape with cabazitaxel.Recommendations for the clinical and radiological evaluation of response to treatment in metastatic renal cell cancer.New advances in genitourinary cancer: evidence gathered in 2014.A Prospective Observational Study for Assessment and Outcome Association of Circulating Endothelial Cells in Clear Cell Renal Cell Carcinoma Patients Who Show Initial Benefit from First-line Treatment. The CIRCLES (CIRCuLating Endothelial cellS) StuNovel potential predictive markers of sunitinib outcomes in long-term responders versus primary refractory patients with metastatic clear-cell renal cell carcinoma.Poxviral-based prostate-specific antigen vaccine in prostate cancer.Gemcitabine plus vinorelbine for the treatment of advanced non-small cell lung cancer.[The maximum standardized uptake value (18)F-FDG PET is independent of the immunohistochemical expression of platelet derived endothelial growth factor in patients with non-small cell lung cancer].Biweekly administration of docetaxel and vinorelbine as second-line chemotherapy for patients with stage IIIB and IV non-small cell lung cancer: a phase II study of the Galician Lung Cancer Group (GGCP 013-02).Radium-223 international early access program: results from the Spanish subset.Development of de novo psoriasis during nivolumab therapy for metastatic renal cell carcinoma: immunohistochemical analyses and clinical outcome.[The immunohistochemical expression of cyclin B1 is associated with higher SUV in 18F-FDG-PET in non-small cell lung cancer patients. Initial results].Treatment Of Sunitinib-Induced Hypertension In Solid Tumors By Nitric Oxid Donors.Sorafenib in renal cell carcinomaAssociation of Salivary Human Papillomavirus Infection and Oral and Oropharyngeal Cancer: A Meta-Analysis
P50
Q33347635-46C59822-7F93-49D4-8FF4-2E28323A3DC2Q33401434-A7D340F1-095A-449F-AD01-984E0C4253B1Q35932363-2A213519-6BA8-46AB-B961-D270EAF32A9BQ38017587-3D8FF677-C8B3-4343-B671-08898EDAED7EQ38068852-A431EDA4-A369-4427-9350-AFAD8F08759FQ38161768-EF82A57D-8146-49F6-87AF-637247053495Q38171376-C46FD23B-539E-45A3-8354-5DD55DCA2E4FQ38557894-84670F69-FDA0-466A-A64A-161542CC4CF5Q38655110-179EB0C3-6A71-488B-B6CC-D0E11C9C3163Q41897121-06317799-9AA3-4038-9C1F-294BF688737EQ43010384-C1C0AF90-B7C3-4A5B-A8DC-150E402DDA16Q43660238-28B2F921-D665-4708-95EA-01BF2D089D94Q46096976-7967119A-0DD5-459F-986F-DC05573D4717Q46983399-7BF40FCC-5812-4490-A5FF-02F028E8ECDFQ47786425-B17AD248-F321-45A6-8654-8D71FA982B38Q52902188-368870AA-0952-482C-ADCF-49738846AA9BQ53356818-31B837F8-6CAC-44FD-ACD7-A10E9E2A2550Q53402453-BFE6AA25-081A-42D8-A436-4C26BC91E094Q83653699-2B6827FC-7CF8-4568-8D5B-DA9656DF0D1FQ94543232-EFC241E6-74B2-4843-85B8-A0A0B39A3941
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Luis León
@ast
Luis León
@en
Luis León
@es
Luis León
@nl
type
label
Luis León
@ast
Luis León
@en
Luis León
@es
Luis León
@nl
prefLabel
Luis León
@ast
Luis León
@en
Luis León
@es
Luis León
@nl
P106
P1153
22034584400
P31
P496
0000-0002-0742-1209